| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030515515 |
| P356 | DOI | 10.1038/EMM.2014.68 |
| P932 | PMC publication ID | 4261912 |
| P698 | PubMed publication ID | 25378232 |
| P5875 | ResearchGate publication ID | 267931481 |
| P2093 | author name string | Hyun-Ju Kim | |
| So Hyun Park | |||
| Young Hwa Kim | |||
| Euy Young Soh | |||
| Jang-Hee Kim | |||
| Jeonghun Lee | |||
| Yong Won Choi | |||
| Tae Jun Park | |||
| Yong Jun Chwae | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance | Q28209900 | ||
| DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 | ||
| The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer | Q28262702 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| DNA methylation, methyltransferases, and cancer | Q30993657 | ||
| Molecular pathogenesis and mechanisms of thyroid cancer | Q34329018 | ||
| BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer | Q34560988 | ||
| Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation | Q35578577 | ||
| The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics | Q36128415 | ||
| BRAF mutation in thyroid cancer | Q36157661 | ||
| Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia | Q36445921 | ||
| Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC). | Q40060705 | ||
| Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor | Q40197347 | ||
| RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells | Q40559173 | ||
| Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression | Q46316325 | ||
| BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer | Q46570559 | ||
| BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis | Q46778071 | ||
| Iodide symporter gene expression in human thyroid tumors | Q47856134 | ||
| Changing trends and prognoses for patients with papillary thyroid cancer. | Q50860524 | ||
| DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. | Q53348394 | ||
| Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. | Q53421611 | ||
| Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant. | Q53569559 | ||
| Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma. | Q54505841 | ||
| The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma | Q54642091 | ||
| The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane | Q60559931 | ||
| BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism | Q61951314 | ||
| BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor kappaB activation | Q64377520 | ||
| Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation | Q67802417 | ||
| The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues | Q68201396 | ||
| Analysis of thyroid carcinoma based on material registered in Japan during 1977-1986 with special reference to predominance of papillary type | Q68234122 | ||
| Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms | Q72132796 | ||
| Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status | Q77997569 | ||
| Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake | Q81248210 | ||
| Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency | Q81797099 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | e120 | |
| P577 | publication date | 2014-11-07 | |
| P1433 | published in | Experimental and Molecular Medicine | Q15758292 |
| P1476 | title | B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1 | |
| P478 | volume | 46 |
| Q98290370 | Appraisal of radioiodine refractory thyroid cancer: advances and challenges |
| Q89543466 | DNA methylation alterations as therapeutic prospects in thyroid cancer |
| Q90575227 | LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer |
| Q39934112 | MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5. |
| Q38758800 | NADPH Oxidase NOX4 Is a Critical Mediator of BRAFV600E-Induced Downregulation of the Sodium/Iodide Symporter in Papillary Thyroid Carcinomas. |
| Q104135085 | Network analysis reveals essential proteins that regulate sodium-iodide symporter expression in anaplastic thyroid carcinoma |
| Q92432285 | THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER |
| Q92286795 | Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma |
Search more.